(Q51058133)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Francesco Ceci

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Stefano Fanti

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Ken Herrmann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Paolo Castellucci

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Tiziano Graziani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Christina Bluemel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Riccardo Schiavina

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Christian Vollmer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Sabine Droll

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Eugenio Brunocilla

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Renzo Mazzarotto

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

15 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Nuclear Medicine and Molecular Imaging

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

2222-2231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-014-2872-x

15 February 2020

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

Choline PET/CT for prostate cancer: Main clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

Dose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: toxicity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

11C-choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2872-X

NCCN clinical practice guidelines in oncology: prostate cancer

21 January 2018

1 reference

12 December 2020

A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy

1 reference

12 December 2020

Influence of 11C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer

1 reference

12 December 2020

A structured debate: immediate versus deferred androgen suppression in prostate cancer-evidence for deferred treatment

1 reference

12 December 2020

Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer

1 reference

12 December 2020

10.1007/S00259-014-2872-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182750%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference